These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 20459753)

  • 1. Hospital costs of central line-associated bloodstream infections and cost-effectiveness of closed vs. open infusion containers. The case of Intensive Care Units in Italy.
    Tarricone R; Torbica A; Franzetti F; Rosenthal VD
    Cost Eff Resour Alloc; 2010 May; 8():8. PubMed ID: 20459753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rate and time to develop first central line-associated bloodstream infections when comparing open and closed infusion containers in a Brazilian Hospital.
    Vilins M; Blecher S; Silva MA; Rosenthal VD; Barker K; Salomao R
    Braz J Infect Dis; 2009 Oct; 13(5):335-40. PubMed ID: 20428631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of switching from an open to a closed infusion system on rates of central line-associated bloodstream infection: a meta-analysis of time-sequence cohort studies in 4 countries.
    Maki DG; Rosenthal VD; Salomao R; Franzetti F; Rangel-Frausto MS
    Infect Control Hosp Epidemiol; 2011 Jan; 32(1):50-8. PubMed ID: 21121815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Should we use closed or open infusion containers for prevention of bloodstream infections?
    Rangel-Frausto MS; Higuera-Ramirez F; Martinez-Soto J; Rosenthal VD
    Ann Clin Microbiol Antimicrob; 2010 Feb; 9():6. PubMed ID: 20122280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Attributable cost and length of stay for central line-associated bloodstream infections.
    Goudie A; Dynan L; Brady PW; Rettiganti M
    Pediatrics; 2014 Jun; 133(6):e1525-32. PubMed ID: 24799537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact on rates and time to first central vascular-associated bloodstream infection when switching from open to closed intravenous infusion containers in a hospital setting.
    Franzetti F; Borghi B; Raimondi F; Rosenthal VD
    Epidemiol Infect; 2009 Jul; 137(7):1041-8. PubMed ID: 19144245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bloodstream Infection in the Intensive Care Unit: Preventable Adverse Events and Cost Savings.
    Dal Forno CB; Correa L; Scatena PD; Silva CV; Shiramizo S; Pavão Dos Santos OF; Cendoroglo Neto M; Teich V; Teich N; Sardenberg C
    Value Health Reg Issues; 2012 Dec; 1(2):136-141. PubMed ID: 29702892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Attributable length of stay and cost for pediatric and neonatal central line-associated bloodstream infections in Greece.
    Karagiannidou S; Zaoutis T; Maniadakis N; Papaevangelou V; Kourlaba G
    J Infect Public Health; 2019; 12(3):372-379. PubMed ID: 30616938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vital signs: central line-associated blood stream infections--United States, 2001, 2008, and 2009.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2011 Mar; 60(8):243-8. PubMed ID: 21368740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Central line bundle including split-septum device and single-use prefilled flushing syringes to prevent port-associated bloodstream infections: a cost and resource-utilization analysis.
    Devrim İ; Özkul MT; Çağlar İ; Oruç Y; Demiray N; Tahta N; Vergin C
    BMC Health Serv Res; 2020 Apr; 20(1):336. PubMed ID: 32316939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is it financially beneficial for hospitals to prevent nosocomial infections?
    Benenson S; Cohen MJ; Schwartz C; Revva M; Moses AE; Levin PD
    BMC Health Serv Res; 2020 Jul; 20(1):653. PubMed ID: 32664922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hospital-acquired infections in Belgian acute-care hospitals: financial burden of disease and potential cost savings.
    Trybou J; Spaepen E; Vermeulen B; Porrez L; Annemans L
    Acta Clin Belg; 2013; 68(3):199-205. PubMed ID: 24156220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation].
    Llorca PM; Miadi-Fargier H; Lançon C; Jasso Mosqueda G; Casadebaig F; Philippe A; Guillon P; Mehnert A; Omnès LF; Chicoye A; Durand-Zaleski I
    Encephale; 2005; 31(2):235-46. PubMed ID: 15959450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The social and economic burden of stroke survivors in Italy: a prospective, incidence-based, multi-centre cost of illness study.
    Fattore G; Torbica A; Susi A; Giovanni A; Benelli G; Gozzo M; Toso V
    BMC Neurol; 2012 Nov; 12():137. PubMed ID: 23150894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inpatient costs, mortality and 30-day re-admission in patients with central-line-associated bloodstream infections.
    Stevens V; Geiger K; Concannon C; Nelson RE; Brown J; Dumyati G
    Clin Microbiol Infect; 2014 May; 20(5):O318-24. PubMed ID: 24112305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hospital-acquired, laboratory-confirmed bloodstream infection: increased hospital stay and direct costs.
    Orsi GB; Di Stefano L; Noah N
    Infect Control Hosp Epidemiol; 2002 Apr; 23(4):190-7. PubMed ID: 12002233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Attributable costs of central line-associated bloodstream infections in a pediatric hematology/oncology population.
    Wilson MZ; Rafferty C; Deeter D; Comito MA; Hollenbeak CS
    Am J Infect Control; 2014 Nov; 42(11):1157-60. PubMed ID: 25444262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The clinical impacts and risk factors for non-central line-associated bloodstream infection in 5046 intensive care unit patients: an observational study based on electronic medical records.
    Zhu S; Kang Y; Wang W; Cai L; Sun X; Zong Z
    Crit Care; 2019 Feb; 23(1):52. PubMed ID: 30777109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A full economic evaluation of extensive vaccination against rotavirus with RIX4414 vaccine at National and Regional level in Italy].
    Vitale F; Barbieri M; Dirodi B; Vitali Rosati G; Franco E
    Ann Ig; 2013; 25(1):43-56. PubMed ID: 23435779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Healthcare-Associated Infections Due to Multidrug-Resistant Organisms: a Surveillance Study on Extra Hospital Stay and Direct Costs.
    Giraldi G; Montesano M; Napoli C; Frati P; La Russa R; Santurro A; Scopetti M; Orsi GB
    Curr Pharm Biotechnol; 2019; 20(8):643-652. PubMed ID: 30961489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.